Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...

First launched in Europe last year, Xofluza became the first influenza antiviral with a new mechanism of action in almost 20 ... for sickle cell disease, Casgevy, has been given the nod for ...

The mechanism of action of ABX464 is triggered by an increased ... Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for use by the NHS in England after ...

H.C. Wainwright analyst Andrew Fein increased the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $550 from the previous $535, while maintaining a Buy rating on the stock.

As well as being essential in the precise packaging of DNA into the space of the nucleus, histone proteins are also the site ...

AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...

Copy number variants (CNVs) arise by homologous recombination (HR) between repeated sequences (recurrent CNVs) or by non-homologous recombination mechanisms that occur throughout the genome (non ...

To curate this list, he dives into Max’s catalogue every month to surface exciting, white-knuckle action titles — using his taste and a lifetime of cinema study as his guide, instead of ...

Action Game Maker builds on the node-based visual scripting system created for Pixel Game Maker MV with many improvements. No knowledge of programming is needed. Simply connect up Actions (similar ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...